Meta CEO, Mark Zuckerbeg and his wife, Priscilla Chan has announced a philanthropic initiative to study human cells and diseases utilising artificial intelligence will be developed by computing system.
The field of biological sciences has been utilising AI for some time. Among the well-known platforms, Google DeepMind’s AlphaFold can forecast protein structures, while Nvidia’s RadImageGAN, an AI radiology model, can detect a variety of illnesses like cancer, heart attacks, and stroke.
“Bringing the power of generative AI to biology at scale will allow researchers to incorporate these technological advances into their work, which will accelerate efforts to cure, prevent, or manage all disease,” Chan said.
Datasets from the programme CZ Cell x Gene, as well as materials from Chan Zuckerberg Biohub Network and Chan Zuckerberg Institute for Advanced Biological Imaging, will be used to train the system. Publicly accessible data will also be used.
The action is being taken as Meta pushes hard to introduce large language models, or LLMs, for companies. Meta gave companies a size a free copy of its most recent Llama 2 model when it was released in July. Both of the models were initially pitched to researchers when its predecessor, Llama, was released in February.
